InsiderClue
Insiders · Profile

Shanafelt Armen

Director at Spyre Therapeutics · Director at Rein Therapeutics · Director at Protagonist Therapeutics. Filing since 16 Aug 2016. CIK 0001656151

SYRE Spyre Therapeutics, Inc. Director · 3 trades RNTX Rein Therapeutics, Inc. Director · 1 trade PTGX Protagonist Therapeutics, Inc Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
SYRE Spyre Therapeutics, Inc.
13 Dec 2021
Director
Bought
14,685
$53.60K
10.9%
SYRE Spyre Therapeutics, Inc.
10 Dec 2021
Director
Bought
13,516
$49.33K
11.1%
SYRE Spyre Therapeutics, Inc.
9 Dec 2021
Director
Bought
121,799
$446.76K
opened
RNTX Rein Therapeutics, Inc.
5 Jul 2017
Director
Bought
250,000
$3.75M
29.6%
PTGX Protagonist Therapeutics, Inc
16 Aug 2016
Director
Bought
583,333
$7.00M
38.5%
5 decisions on file.